Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach

• Main Authors: Salto-Tellez M., Tsao M., Shih J., Thongprasert S., Lu S., Chang G., Au J., Chou T., Lee J., Shi Y., Radzi A., Kang J., Kim S., Tan S., Yang J.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80053023140&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42987
• Institution: Chiang Mai University

Background: Several randomized phase III studies in advanced stage non-small cell lung cancer (NSCLC) confirmed the superior response rate and progression-free survival of using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor as first-line therapy compared with chemotherapy in pati...